Top Health Care companies in the world by Net Income Margin

This ranking features the top 2,383 Health Care companies in the world ranked by Net Income Margin, averaging a Net Income Margin of -845,717.00%, for January 15, 2025.

Global

Health Care

#	Name	Net Income Margin	Reported Date	Stock Price	Change	Country
1	Inhibrx Biosciences, Inc. 1 INBX	94,684.72%	Sept. 30, 2024	USD 12.74	-6.60%	United States
2	Roivant Sciences Ltd. 2 ROIV	3,484.86%	March 31, 2024	USD 10.94	1.86%	United Kingdom
3	Eledon Pharmaceuticals, Inc. 3 ELDN	2,168.39%	Sept. 30, 2024	USD 3.71	-4.63%	United States
4	Agios Pharmaceuticals, Inc. 4 AGIO	2,051.38%	Sept. 30, 2024	USD 33.32	-2.86%	United States
5	Oramed Pharmaceuticals Inc. 5 ORMP	1,551.34%	March 31, 2024	USD 2.36	NA	United States
6	Immuneering Corporation 6 IMRX	1,085.06%	Sept. 30, 2023	USD 1.95	-2.99%	United States
7	MPH Health Care AG 7 93M1.DE	408.26%	Dec. 31, 2023	USD 24.32	-0.24%	Germany
8	RedHill Biopharma Ltd. 8 RDHL	367.19%	Dec. 31, 2023	USD 5.51	-1.08%	Israel
9	Oncimmune Holdings plc 9 ONC.L	356.25%	Aug. 31, 2023	USD 0.16	-0.68%	United Kingdom
10	Pharmena S.A. 10 PHR.WA	294.21%	Dec. 31, 2023	USD 1.01	1.23%	Poland
11	Alembic Limited 11 ALEMBICLTD.NS	170.57%	March 31, 2024	USD 1.41	4.27%	India
12	Summerset Group Holdings Limited 12 SUM.NZ	161.30%	Dec. 31, 2023	USD 7.11	0.74%	New Zealand
13	TaiGen Biopharmaceuticals Holdings Limited 13 4157.TWO	111.04%	Dec. 31, 2023	USD 0.32	0.12%	Taiwan
14	Formycon AG 14 FYB.DE	97.55%	Dec. 31, 2023	USD 60.50	-1.24%	Germany
15	Cipher Pharmaceuticals Inc. 15 CPH.TO	96.32%	Dec. 31, 2023	USD 9.40	-4.39%	Canada
16	Galapagos NV 16 GLPG.AS	88.31%	Dec. 31, 2023	USD 24.20	-0.41%	Belgium
17	Alar Pharmaceuticals Inc. 17 6785.TWO	81.53%	Dec. 31, 2023	USD 4.09	5.18%
18	Edwards Lifesciences Corporation 18 EW	70.82%	Sept. 30, 2024	USD 71.04	-0.07%	United States
19	L&C Bio Co., Ltd 19 290650.KQ	70.22%	Dec. 31, 2023	USD 16.30	-3.69%	South Korea
20	Bioventix PLC 20 BVXP.L	59.51%	June 30, 2024	USD 39.06	2.49%	United Kingdom
21	Kangji Medical Holdings Limited 21 9997.HK	54.43%	Dec. 31, 2023	USD 0.77	2.02%	China
22	Santhera Pharmaceuticals Holding AG 22 SANN.SW	52.97%	Dec. 31, 2023	USD 14.50	8.00%	Switzerland
23	Protagonist Therapeutics, Inc. 23 PTGX	52.76%	Sept. 30, 2024	USD 36.67	-1.26%	United States
24	Pro Medicus Limited 24 PME.AX	51.27%	June 30, 2024	USD 157.25	0.24%	Australia
25	Royalty Pharma plc 25 RPRX	50.54%	Sept. 30, 2024	USD 30.03	0.13%	United States
26	SIGA Technologies, Inc. 26 SIGA	49.33%	Sept. 30, 2024	USD 6.33	4.46%	United States
27	Yantai Zhenghai Biotechnology Co., Ltd. 27 300653.SZ	46.16%	Dec. 31, 2023	USD 2.82	2.48%	China
28	ORIENT BIO Inc. 28 002630.KS	45.96%	March 31, 2024	USD 1.22	1.14%	South Korea
29	Shanghai Yizhong Pharmaceutical Co., Ltd. 29 688091.SS	44.84%	Dec. 31, 2023	USD 4.94	3.02%	China
30	Akeso, Inc. 30 9926.HK	44.81%	Dec. 31, 2023	USD 7.28	2.32%	China
31	Beijing Succeeder Technology Inc. 31 688338.SS	42.44%	Dec. 31, 2023	USD 3.27	2.18%	China
32	Jilin Aodong Pharmaceutical Group Co., Ltd. 32 000623.SZ	42.33%	Dec. 31, 2023	USD 2.25	3.72%	China
33	EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. 33 ECILC.IS	42.28%	Dec. 31, 2023	USD 1.24	-0.32%	Turkey
34	Shenzhen New Industries Biomedical Engineering Co., Ltd. 34 300832.SZ	42.08%	Dec. 31, 2023	USD 8.51	2.10%	China
35	Shanghai MicroPort Endovascular MedTech Co., Ltd. 35 688016.SS	41.90%	Dec. 31, 2023	USD 15.35	4.46%	China
36	Bonesupport Holding AB (publ) 36 BONEX.ST	41.45%	Dec. 31, 2023	USD 32.97	-0.61%	Sweden
37	Halozyme Therapeutics, Inc. 37 HALO	41.43%	Sept. 30, 2024	USD 53.83	-0.57%	United States
38	Giant Biogene Holding Co., Ltd. 38 2367.HK	41.19%	Dec. 31, 2023	USD 6.64	6.03%	China
39	Beijing SL Pharmaceutical Co., Ltd. 39 002038.SZ	40.92%	Dec. 31, 2023	USD 1.04	1.87%	China
40	Pak Fah Yeow International Limited 40 0239.HK	40.51%	Dec. 31, 2023	USD 0.31	0.39%	Hong Kong
41	Clinuvel Pharmaceuticals Limited 41 CUV.AX	40.41%	June 30, 2024	USD 7.32	6.16%	Australia
42	United Therapeutics Corporation 42 UTHR	40.31%	Sept. 30, 2024	USD 364.70	0.50%	United States
43	G&E Herbal Biotechnology Co., Ltd. 43 4911.TWO	39.90%	Dec. 31, 2023	USD 1.63	0.49%
44	Jenkem Technology Co., Ltd. 44 688356.SS	39.62%	Dec. 31, 2023	USD 7.16	2.79%	China
45	Genovis AB (publ.) 45 GENO.ST	38.87%	Dec. 31, 2023	USD 2.09	-2.04%	Sweden
46	Andon Health Co., Ltd. 46 002432.SZ	38.74%	Dec. 31, 2023	USD 5.45	2.10%	China
47	Tonghua Dongbao Pharmaceutical Co., Ltd. 47 600867.SS	37.97%	Dec. 31, 2023	USD 1.05	3.24%	China
48	Shionogi & Co., Ltd. 48 4507.T	37.24%	March 31, 2024	USD 14.22	-0.40%	Japan
49	BioArctic AB (publ) 49 BIOA-B.ST	37.22%	Dec. 31, 2023	USD 17.87	3.09%	Sweden
50	Wuhan Keqian Biology Co.,Ltd 50 688526.SS	37.21%	Dec. 31, 2023	USD 1.78	1.80%	China

1 2 3 4 … 48

Frequently Asked Questions

Which Health Care company has the highest Net Income Margin ?

The Health Care company with the highest Net Income Margin is Inhibrx Biosciences, Inc. (NasdaqGS: INBX) at 94,684.72%.
Which Health Care company has the lowest Net Income Margin ?

The Health Care company with the lowest Net Income Margin is Inhibikase Therapeutics, Inc. (NasdaqCM: IKT) at -1,956,524,900.00%.

What are the top 10 Health Care companies by Net Income Margin ?

The top 10 Health Care companies the Global by Net Income Margin are Inhibrx Biosciences, Inc., Roivant Sciences Ltd., Eledon Pharmaceuticals, Inc., Agios Pharmaceuticals, Inc., Oramed Pharmaceuticals Inc., Immuneering Corporation, MPH Health Care AG, RedHill Biopharma Ltd., Oncimmune Holdings plc and Pharmena S.A..
What are the bottom 10 Health Care companies by Net Income Margin ?

The bottom 10 Health Care companies by Net Income Margin are Inhibikase Therapeutics, Inc., Molecure S.A., ZyVersa Therapeutics, Inc., Inovio Pharmaceuticals, Inc., BrightPath Biotherapeutics Co., Ltd., Genomtec S.A., Summit Therapeutics Inc., Allogene Therapeutics, Inc., Forte Biosciences, Inc. and OncoZenge AB (publ).